A Prognostic Score for Advanced Hodgkin's Disease

19981,724 citationsJournal Articlebronze Open Access

Authors

Dirk Hasenclever · Leipzig University

Volker Diehl · University of Cologne

Abstract

The prognostic score we developed may be useful in designing clinical trials for the treatment of advanced Hodgkin's disease and in making individual therapeutic decisions, but a distinct group of patients at very high risk could not be identified on the basis of routinely documented demographic and clinical characteristics.

Topics & Keywords

Lymphoma Diagnosis and Treatment Chronic Lymphocytic Leukemia Research Lung Cancer Treatments and Mutations

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 339, Issue 21, pp. 1506-1514

DOI: 10.1056/nejm199811193392104

Field-Weighted Citation Impact: 19.74